Status:
RECRUITING
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
Lead Sponsor:
Henan Provincial People's Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Brief Summary
The success rate of single-procedure atrial arrhythmia-free survival particularly ranged from 40% to 66% in persistent AF ablation. However, The surgical Cox maze III procedure has been established to...
Eligibility Criteria
Inclusion
- Radiofrequency catheter ablation for the first time
- AF rhythm recorded by ECG
Exclusion
- Thrombosis in left atrium
- Left ventricular ejection fraction of \< 35%
- Abnormal thyroid function
- Previous history of AF radiofrequency ablation and CABG
- Left atrium diameter of \> 65 mm or the volume of \> 200 ml
Key Trial Info
Start Date :
December 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06145906
Start Date
December 26 2023
End Date
December 1 2026
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Henan Provincial People's Hospital
Zhengzhou, Henan, China, 450000